[HTML] mdpi.com

[HTML][HTML] Delineation of molecular lesions in acute myeloid leukemia patients at diagnosis: integrated next generation sequencing and cytogenomic studies

SM Papuc, A Erbescu, D Cisleanu, D Ozunu, C Enache… - Genes, 2021 - mdpi.com
Acute myeloid leukemia (AML) is a heterogeneous disorder characterized by a wide range
of genetic defects. Cytogenetics, molecular and genomic technologies have proved to be …
被引用次数：5 相关文章

Delineation of Molecular Lesions in Acute Myeloid Leukemia Patients at Diagnosis: Integrated Next Generation Sequencing and Cytogenomic Studies

SM Papuc, A Erbescu, D Cisleanu, D Ozunu… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) is a heterogeneous disorder characterized by a wide range
of genetic defects. Cytogenetics, molecular and genomic technologies have proved to be …

Delineation of Molecular Lesions in Acute Myeloid Leukemia Patients at Diagnosis: Integrated Next Generation Sequencing and Cytogenomic Studies

SM Papuc, A Erbescu, D Cisleanu, D Ozunu, C Enache… - Genes, 2021 - agris.fao.org
Acute myeloid leukemia (AML) is a heterogeneous disorder characterized by a wide range
of genetic defects. Cytogenetics, molecular and genomic technologies have proved to be …

Delineation of Molecular Lesions in Acute Myeloid Leukemia Patients at Diagnosis: Integrated Next Generation Sequencing and Cytogenomic Studies.

SM Papuc, A Erbescu, D Cisleanu, D Ozunu… - …, 2021 - search.ebscohost.com
Acute myeloid leukemia (AML) is a heterogeneous disorder characterized by a wide range
of genetic defects. Cytogenetics, molecular and genomic technologies have proved to be …

Delineation of Molecular Lesions in Acute Myeloid Leukemia Patients at Diagnosis: Integrated Next Generation Sequencing and Cytogenomic Studies.

SM Papuc, A Erbescu, D Cisleanu, D Ozunu, C Enache… - Genes, 2021 - europepmc.org
Acute myeloid leukemia (AML) is a heterogeneous disorder characterized by a wide range
of genetic defects. Cytogenetics, molecular and genomic technologies have proved to be …
[HTML] nih.gov

[HTML][HTML] Delineation of Molecular Lesions in Acute Myeloid Leukemia Patients at Diagnosis: Integrated Next Generation Sequencing and Cytogenomic Studies

SM Papuc, A Erbescu, D Cisleanu, D Ozunu, C Enache… - Genes, 2021 - ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) is a heterogeneous disorder characterized by a wide range
of genetic defects. Cytogenetics, molecular and genomic technologies have proved to be …

Delineation of Molecular Lesions in Acute Myeloid Leukemia Patients at Diagnosis: Integrated Next Generation Sequencing and Cytogenomic Studies

SM Papuc, A Erbescu, D Cisleanu, D Ozunu… - Genes, 2021 - search.proquest.com
Acute myeloid leukemia (AML) is a heterogeneous disorder characterized by a wide range
of genetic defects. Cytogenetics, molecular and genomic technologies have proved to be …
[PDF] academia.edu

[PDF][PDF] Delineation of Molecular Lesions in Acute Myeloid Leukemia Patients at Diagnosis: Integrated Next Generation Sequencing and Cytogenomic Studies. Genes …

SM Papuc, A Erbescu, D Cisleanu, D Ozunu, C Enache… - 2021 - academia.edu
Acute myeloid leukemia (AML) is a heterogeneous disorder characterized by a wide range
of genetic defects. Cytogenetics, molecular and genomic technologies have proved to be …
[PDF] academia.edu

[PDF][PDF] Delineation of Molecular Lesions in Acute Myeloid Leukemia Patients at Diagnosis: Integrated Next Generation Sequencing and Cytogenomic Studies. Genes …

SM Papuc, A Erbescu, D Cisleanu, D Ozunu, C Enache… - 2021 - academia.edu
Acute myeloid leukemia (AML) is a heterogeneous disorder characterized by a wide range
of genetic defects. Cytogenetics, molecular and genomic technologies have proved to be …

[引用][C] Delineation of Molecular Lesions in Acute Myeloid Leukemia Patients at Diagnosis: Integrated Next Generation Sequencing and Cytogenomic Studies

SM Papuc, A Erbescu, D Cisleanu, D Ozunu, C Enache… - 2021